TrialAmerican journal of hematology2026

Better 10-Year Cerebrovascular Outcome After Transplant Than on Standard-Care in Sickle Cell Anemia: DREPAGREFFE Trial.

Francoise Bernaudin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.